- Medibank Private reported an underlying profit of A$570.4 million for FY 2024, up 14% year-on-year.
- Net income surged by 60% year-on-year, reaching A$492.5 million.
- The final dividend per share increased to A$0.0940 from A$0.083 the previous year.
- Net investment income stood at A$182.2 million.
- Health insurance premium revenue grew by 7.6% year-on-year, totaling A$7.62 billion.
- Total revenue amounted to A$8.18 billion, a 4.7% increase year-on-year, meeting the estimated A$8.18 billion.
- Health Insurance revenue came in at A$7.90 billion, slightly above the A$7.88 billion estimate.
- Medibank Health revenue saw a substantial 32% year-on-year increase, reaching A$272.8 million.
- Group operating profit, excluding COVID-19 impacts, showed a 6.3% rise in Health Insurance operating profit.
- Strong growth was observed in the Medibank Health segment profit.
- The finalization of the customer give-back program is expected to be announced in FY25.
- Medibank anticipates continued solid policy unit growth in FY25.
- The company is targeting average organic profit growth of ≥15% per annum between FY24 and FY26 in Medibank Health.
- Analyst recommendations include 5 buys and 6 holds, with no sells.
A look at Medibank Private Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 3 | |
| Growth | 4 | |
| Resilience | 4 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Medibank Private Limited, a provider of private health care services in Australia, has garnered positive Smart Scores in various aspects. With a solid growth score of 4, the company shows promising potential for long-term expansion. Coupled with resilient operations and momentum in its performance, Medibank appears well-positioned for sustained growth in the future. Additionally, the company’s focus on dividends and value also contributes to its overall positive outlook, reflecting a balanced approach to investor returns.
In conclusion, Medibank Private Limited, known for its diverse health insurance offerings catering to a wide range of customers, demonstrates strength across multiple Smart Scores including growth, resilience, and momentum. While there are areas for improvement, such as the value score, the overall outlook for the company appears favorable based on its demonstrated strengths in key operational areas. Investors may find Medibank Private a potentially attractive long-term investment opportunity given its solid performance across different factors.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
